Recent Finacing
Recent Raise
Immunic AG is a clinical-stage biotech developing orally available small-molecule immune modulators, including DHODH inhibitor IMU-838 and RORγt inverse agonist IMU-366 for IBD and psoriasis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Immunic Therapeutics.
